Option chain shows key data for PhenixFIN's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for PhenixFIN.

PhenixFIN (NASDAQ:PFX) Stock, Option Chain

Phoenix Companies, Inc. (The)

NYSE

PhenixFIN

Medley Capital

PhenixFIN Corp formerly Medley Capital Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

Long Ideas

News

Small Cap

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

FRSH

PHAT

Although US stocks closed mixed on Tuesday, there were a few notable insider trades.

$14M Bet On This Technology Stock? Check Out These 4 Stocks Insiders Are Buying

The Phoenix Companies Reports Success of Consent Solicitation, Says Will Give Restatement Update by June 30th

Financing

The Phoenix Companies Announces Consent Solicitation Relating to 7.45% Quarterly Interest Bonds due 2032 and Provides Restatement Update 

PhenixFIN Corp

VanEck Preferred Securities ex Financials ETF

PhenixFIN Corporation - 5.25% Notes due 2028

PhenixFIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFX#NASDAQ">PFX</a>) reported quarterly earnings of $9.13 per share which beat the analyst consensus estimate of $7.25 by 25.93 percent. The company reported quarterly sales of $22.18 million which missed the analyst consensus estimate of $23.82 million by 6.88 percent. This is a 10.18 percent increase over sales of $20.13 million the same period last year.

Earnings

PhenixFIN FY 2024 GAAP EPS $9.13 Beats $7.25 Estimate, Investment Income $22.18M Miss $23.82M Estimate

WIIM

JNVR

KSPI

LGHL

STEC

VALU

Shares of companies within the broader financial sector are trading lower possibly amid overall market weakness.

ALTI

CNFR

CRBG

HOOD

IBKR

NTRS

UPST

WENA

Shares of companies within the broader financial sector are trading lower amid overall market weakness as investors react to jobs data.

PhenixFIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFX#NASDAQ">PFX</a>) reported quarterly earnings of $1.29 per share which beat the analyst consensus estimate of $0.65 by 98.46 percent. This is a 122.41 percent increase over earnings of $0.58 per share from the same period last year. The company reported quarterly sales of $6.23 million which beat the analyst consensus estimate of $5.17 million by 20.60 percent. This is a 28.85 percent increase over sales of $4.84 million the same period last year.

Earnings Beats

PhenixFIN Q3 EPS $1.29, Sales $6.23M Beat $5.17M Estimate

PhenixFIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFX#NASDAQ">PFX</a>) reported quarterly sales of $4.658 million which missed the analyst consensus estimate of $5.601 million by 16.84 percent. This is a 5.18 percent decrease over sales of $4.912 million the same period last year.

Earnings Misses

PhenixFIN Q2 Sales $4.658M Miss $5.601M Estimate

Dividends

PhenixFIN Declares Special Dividend Of $1.31/Share

PhenixFIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFX#NASDAQ">PFX</a>) reported quarterly earnings of $2.19 per share which beat the analyst consensus estimate of $0.78 by 180.77 percent. This is a 180.77 percent increase over earnings of $0.78 per share from the same period last year. The company reported quarterly sales of $5.72 million which beat the analyst consensus estimate of $5.51 million by 3.84 percent. This is a 21.66 percent increase over sales of $4.70 million the same period last year.

PhenixFIN Q1 GAAP EPS $2.19, Sales $5.72M Beat $5.51M Estimate

PhenixFIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFX#NASDAQ">PFX</a>) reported quarterly sales of $5.72 million which beat the analyst consensus estimate of $5.51 million by 3.84 percent. This is a 21.66 percent increase over sales of $4.70 million the same period last year.

PhenixFIN Q1 Sales $5.72M Beat $5.51M Estimate

PhenixFIN Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFX#NASDAQ">PFX</a>, PFXNZ)))) (the &quot;Company&quot;), a publicly traded business development company, today announced its financial results for the fiscal fourth quarter of 2023.
Highlights
<ul>
<li>Fourth quarter total investment income of $5.7 million; net investment income of $1.9 million</li>
<li>Net asset value (NAV) of $146.7 million, or $70.75 per share as of September 30, 2023, vs. $57.49 per share as of September 30, 2022</li>
<li>Weighted average yield was 13.3% on debt and other income producing investments as of the fiscal year end</li>
<li>Repurchased 28,416 shares in Fiscal Year 2023</li>
</ul>
David Lorber, Chief Executive Officer of the Company, stated:
&quot;We are pleased with our performance in 2023 as we grew NAV per share 23%, from $57.29 per share to $70.75 per share, along with NII per share growth of 110%, from $1.48 per share to $3.11 per share. We look to continue to execute on our investment strategy through credit, equity, and other bespoke investment opportunities.&quot;
Selected Fourth Quarter 2023 Financial Results for the Quarter Ended September 30, 2023:
Total investment income was $5.7 million of which $5.6 million was attributable to portfolio interest and dividend income and $0.1 million was attributable to fee and other income.
Total net expenses were $3.8 million and total net investment income was $1.9 million.
The Company recorded a net realized loss of $9.4 million and net unrealized gain of $14.9 million.
Portfolio and Investment Activities for the Quarter Ended September 30, 2023:
&nbsp;
The fair value of the Company&#39;s investment portfolio totaled $226.5 million and consisted of 42 portfolio companies.
The Company had 4 portfolio company investments on non-accrual status with a fair market value of $6.5 million.
Liquidity and Capital Resources
At September 30, 2023, the Company had $6.0 million in cash and cash equivalents, $57.5 million in aggregate principal amount of its 5.25% unsecured notes due 2028 and $28.4 million outstanding under the Credit Facility.

PhenixFIN Reports FY23 NAV Per Share Grew 23%, From $57.29 Per Share To $70.75 Per Share; Q4 Total Investment Income Of $5.7M

PhenixFIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFX#NASDAQ">PFX</a>) reported quarterly earnings of $0.58 per share which missed the analyst consensus estimate of $0.78 by 25.64 percent. This is a 544.44 percent increase over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $4.84 million which missed the analyst consensus estimate of $4.89 million by 1.04 percent. This is a 32.25 percent increase over sales of $3.66 million the same period last year.

PhenixFIN Q3 EPS $0.58 Misses $0.78 Estimate, Sales $4.84M Miss $4.89M Estimate

PhenixFIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFX#NASDAQ">PFX</a>) reported quarterly earnings of $0.85 per share which beat the analyst consensus estimate of $0.78 by 8.97 percent. This is a 77.08 percent increase over earnings of $0.48 per share from the same period last year. The company reported quarterly sales of $4.91 million which beat the analyst consensus estimate of $4.57 million by 7.49 percent. This is a 34.33 percent increase over sales of $3.66 million the same period last year.

PhenixFIN Q2 EPS $0.85 Beats $0.78 Estimate, Sales $4.91M Beat $4.57M Estimate

Although US stocks closed mixed on Tuesday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#39;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h2>Impinj </h2>
<ul>
<li>The Trade: Impinj, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pi#NASDAQ">PI</a>) Director Patrick Daniel Gibson <a href="https://www.benzinga.com/quote/PI/analyst-ratings"> acquired a total of 111,697 shares </a> an average price of $125.13. To acquire these shares, it cost around $13.98 million.</li>
<li>What&rsquo;s Happening: The company recently posted upbeat quarterly results.</li>
<li>What Impinj Does: Impinj Inc operates a platform that enables wireless connectivity to everyday items by delivering each item&#39;s identity, location, and authenticity to business and consumer applications.</li>
</ul>
<h2>PhenixFIN </h2>
<ul>
<li>The Trade: PhenixFIN Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pfx#NASDAQ">PFX</a>) Chairman and CEO David A Lorber <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 3,063 shares at </a> an average price of $36.19. To acquire these shares, it cost around $110.84 thousand.</li>
<li>What&rsquo;s Happening: PhenixFIN recently posted a rise in quarterly earnings.</li>
<li>What PhenixFIN Does: PhenixFIN Corp formerly Medley Capital Corp is a non-diversified closed end management investment company operating in United States.</li>
</ul>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
<h2>Freshworks </h2>
<ul>
<li>The Trade: Freshworks Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frsh#NASDAQ">FRSH</a>) 10% owner Sumir Chadha <a href="https://www.benzinga.com/sec/insider-trades/"> bought a total of 279,564 shares </a> at an average price of $15.78. To acquire these shares, it cost around $4.41 million.</li>
<li>What&rsquo;s Happening: Freshworks recently posted better-than-expected quarterly earnings.</li>
<li>What Freshworks Does: Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/23/02/30919292/us-stocks-settle-mixed-investor-optimism-improves"> US Stocks Settle Mixed; Investor Optimism Improves </a>
<h2>Phathom Pharmaceuticals </h2>
<ul>
<li>The Trade: Phathom Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phat#NASDAQ">PHAT</a>) Director Asit Parikh <a href="https://www.benzinga.com/sec/insider-trades/"> bought a total 5,000 shares </a> at an average price of $7.73. The insider spent around $38.66 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: The FDA formally asked for additional stability data to demonstrate that levels of the impurity previously found in Phathom Pharmaceuticals&rsquo; vonoprazan drug product will remain at or below the daily acceptable intake throughout the proposed shelf life of the product.</li>
<li>What Phathom Pharmaceuticals Does: Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company.</li>
</ul>

PhenixFIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFX#NASDAQ">PFX</a>) reported quarterly earnings of $0.78 per share. This is a 875 percent increase over earnings of $0.08 per share from the same period last year. The company reported $1.65 million in sales this quarter. This is a 723.87 percent increase over sales of $200.11 thousand the same period last year.

PhenixFIN Q1 EPS $0.78 Up From $0.08 YoY, Sales $1.65M Up From $200.11K YoY

PhenixFIN Q4 Net Investment Income $1.9M

Brightwood Capital Advisors (&quot;Brightwood&quot;), a leading private credit firm, and PhenixFIN Corporation (&quot;PhenixFIN&quot;), a publicly traded business development company, announced today that they have provided debt and equity financing to support CCP Capital Strategies&#39; (&quot;CCP&quot;) acquisition of&nbsp;100 percent&nbsp;of Wireless Maritime Services, LLC (&quot;WMS&quot;) stock from AT&amp;T and Anuvu.
Formed in 2005 and headquartered in Miramar, Florida, WMS provides maritime cellular networks enabling secure, high-performance connectivity at sea. WMS&#39; existing management team will continue to lead to the business, which will now operate as an independent platform.
&quot;We are pleased to partner with PhenixFIN to provide a customized financing solution in support of CCP&#39;s acquisition of Wireless Maritime Services especially given their success in the technology and telecommunications sector, which is a core market where we see continued growth opportunity,&quot; said Sengal Selassie, Chief Executive Officer and Managing Partner at Brightwood. &quot;Brightwood&#39;s broad capabilities to serve borrowers across various stages of their business&#39;s life cycle is an essential aspect of our investment strategy. Wireless Maritime Services has been an industry leader for over 15 years, and we look forward to their continued success, further bolstered by growth in consumer data consumption.&quot;
&quot;We are highly impressed by the WMS team, their strong expertise, and impressive growth story. We are excited to have the opportunity to partner with WMS, Brightwood, and CCP to help WMS grow its customer base and offer consumers more choices to stay connected while they are traveling,&quot; said David Lorber, Chief Executive Officer at PhenixFIN.
&quot;Brightwood and PhenixFIN were great partners, demonstrating tremendous flexibility throughout all phases of the acquisition,&quot; said David Collier, Managing Partner at CCP. &quot;Their insights during diligence were invaluable and we look forward to growing WMS together with them.&quot;
About CCP Capital Strategies
CCP Capital is a private equity investment firm focused on companies operating in specialty communications, aerospace and government services. The firm specializes in working with founder-operators and in executing seamless divestitures to build best-in-class middle market companies. CCP has offices in Greenwich, CT and Atlanta, GA. For more information, please visit:&nbsp;<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.ccpcap.com&amp;esheet=52946889&amp;newsitemid=20221018005555&amp;lan=en-US&amp;anchor=www.ccpcap.com&amp;index=1&amp;md5=ae7f6ad19de32fda0e4022751587069e">www.ccpcap.com</a>.

Brightwood Capital Advisors And PhenixFIN Lead Financing To Support CCP Capital Strategies' Acquisition Of Wireless Maritime Services

PhenixFIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFX#NASDAQ">PFX</a>) reported quarterly earnings of $0.08 per share. This is a 97.39 percent decrease over earnings of $3.06 per share from the same period last year.

PhenixFIN Q1 EPS $0.08 Down From $3.06 YoY

PhenixFIN Corporation Reports Q4 Total Investment Income Of $4.4M

&nbsp;
<h1>&nbsp;</h1>
Before 10 a.m. ET on Wednesday, 77 companies hit new 52-week highs.
<h2>Areas of Significance:</h2>
<ul>
<li>Pfizer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) was the largest firm on a market cap basis to set a new 52-week high.</li>
<li>The smallest company by market cap to set a new 52-week high was PhenixFIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFX#NASDAQ">PFX</a>).</li>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) was the biggest winner of the morning session, as it traded up 57.85% to reach its new 52-week high.</li>
</ul>
The following stocks set new 52-week highs during the first half-hour of trading on Wednesday:
<ul>
<li>Pfizer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) shares set a new 52-week high of $51.76 on Wednesday, moving up 1.75%.</li>
<li>Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) stock made a new 52-week high of $105.67 Wednesday. The stock was up 0.5% for the day.</li>
<li>Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) shares achieved a new 52-week high on Wednesday morning, hitting $323.42 with a daily change of down 0.05%.</li>
<li>AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) shares achieved a new 52-week high on Wednesday morning, hitting $119.92 with a daily change of down 0.11%.</li>
<li>Costco Wholesale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) stock on Wednesday broke to a yearly high of $455.24. Shares traded up 0.24%.</li>
<li>Sea (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SE#NYSE">SE</a>) shares set a new yearly high of $319.01 this morning. The stock was up 2.04% on the session.</li>
<li>Linde (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LIN#NYSE">LIN</a>) shares were up 0.71% for the day, having made a 52-week high of $314.37.</li>
<li>Charter Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) shares achieved a new 52-week high on Wednesday morning, hitting $793.00 with a daily change of up 0.58%.</li>
<li>Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) shares hit a yearly high of $1,049.00. The stock traded up 1.34% on the session.</li>
<li>GlaxoSmithKline (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>) shares hit a yearly high of $42.68. The stock traded up 0.65% on the session.</li>
<li>Infosys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFY#NYSE">INFY</a>) stock made a new 52-week high of $23.87 Wednesday. The stock was up 1.08% for the day.</li>
<li>Prologis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLD#NYSE">PLD</a>) shares hit a new 52-week high of $134.25. The stock traded down 0.71% on the session.</li>
<li>Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) shares hit a new 52-week high of $73.32. The stock traded down 0.03% on the session.</li>
<li>Chubb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>) shares were up 0.66% on Wednesday morning to hit a new 52-week high of $186.44.</li>
<li>Edwards Lifesciences (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>) shares were up 0.67% for the day, having made a 52-week high of $118.18.</li>
<li>Regeneron Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) stock made a new 52-week high of $650.63 Wednesday. The stock was up 0.19% for the day.</li>
<li>America Movil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMOV#NYSE">AMOV</a>) stock set a new 52-week high of $17.86 Wednesday morning. Over the session, the stock traded up 0.04%.</li>
<li>America Movil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMX#NYSE">AMX</a>) shares set a new yearly high of $17.94 this morning. The stock was up 0.28% on the session.</li>
<li>Public Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSA#NYSE">PSA</a>) stock made a new 52-week high of $321.11 Wednesday. The stock was up 0.47% for the day.</li>
<li>Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) shares hit a new 52-week high of $165.22. The stock traded up 1.87% on the session.</li>
<li>IQVIA Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) stock set a new 52-week high of $258.92 Wednesday morning. Over the session, the stock traded up 0.72%.</li>
<li>BCE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCE#NYSE">BCE</a>) shares broke to $51.38 on Wednesday, setting a new 52-week high with a change of up 0.11%.</li>
<li>ResMed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>) shares were up 0.73% on Wednesday to hit a new 52-week high of $283.07 for a change of up 0.73%.</li>
<li>Yum Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>) shares were up 0.36% for the day, having made a 52-week high of $135.77.</li>
<li>Motorola Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSI#NYSE">MSI</a>) shares set a new 52-week high of $235.63 on Wednesday, moving up 0.36%.</li>
<li>Alcon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALC#NYSE">ALC</a>) shares reached a new 52-week high of $80.54 on Wednesday morning, moving up 10.85%.</li>
<li>EPAM Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPAM#NYSE">EPAM</a>) shares hit $627.88 on Wednesday morning, setting a new 52-week high for a change of up 1.21%.</li>
<li>Kroger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) shares broke to $45.78 on Wednesday, setting a new 52-week high with a change of up 0.62%.</li>
<li>West Pharmaceutical Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WST#NYSE">WST</a>) stock made a new 52-week high of $445.75 Wednesday. The stock was up 0.55% for the day.</li>
<li>Liberty Broadband (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBRDA#NASDAQ">LBRDA</a>) shares achieved a new 52-week high on Wednesday morning, hitting $180.33 with a daily change of up 0.29%.</li>
<li>Old Dominion Freight Line (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODFL#NASDAQ">ODFL</a>) shares set a new yearly high of $282.04 this morning. The stock was up 0.25% on the session.</li>
<li>Gartner (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) shares set a new yearly high of $312.58 this morning. The stock was up 0.62% on the session.</li>
<li>Ameren (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEE#NYSE">AEE</a>) stock hit a yearly high price of $90.12. The stock was down 0.4% for the day.</li>
<li>Charles River (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRL#NYSE">CRL</a>) shares were up 1.18% on Wednesday to hit a new 52-week high of $423.63 for a change of up 1.18%.</li>
<li>Upstart Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) shares were up 6.29% on Wednesday morning to hit a new 52-week high of $216.39.</li>
<li>Brown &amp; Brown (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>) stock set a new 52-week high of $56.79 Wednesday morning. Over the session, the stock traded up 0.31%.</li>
<li>Evergy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVRG#NYSE">EVRG</a>) shares were down 0.07% on Wednesday to hit a new 52-week high of $69.16 for a change of down 0.07%.</li>
<li>Maravai LifeSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVI#NASDAQ">MRVI</a>) shares set a new 52-week high of $60.17 on Wednesday, moving up 1.48%.</li>
<li>Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) stock set a new 52-week high of $343.90 Wednesday morning. Over the session, the stock traded up 9.95%.</li>
<li>Repligen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGEN#NASDAQ">RGEN</a>) shares hit a new 52-week high of $261.91. The stock traded up 1.75% on the session.</li>
<li>Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) shares hit $288.27 on Wednesday morning, setting a new 52-week high for a change of down 0.16%.</li>
<li>CubeSmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUBE#NYSE">CUBE</a>) stock hit a yearly high price of $51.23. The stock was up 0.33% for the day.</li>
<li>Genpact (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) shares set a new yearly high of $52.46 this morning. The stock was up 0.61% on the session.</li>
<li>Juniper Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNPR#NYSE">JNPR</a>) shares were up 2.25% on Wednesday to hit a new 52-week high of $29.11 for a change of up 2.25%.</li>
<li>Endava (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVA#NYSE">DAVA</a>) shares were up 1.12% on Wednesday morning to hit a new 52-week high of $141.54.</li>
<li>First American Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FAF#NYSE">FAF</a>) shares set a new 52-week high of $69.17 on Wednesday, moving up 0.5%.</li>
<li>BJ&#39;s Wholesale Club (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>) shares set a new 52-week high of $53.65 on Wednesday, moving up 1.61%.</li>
<li>Watts Water Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTS#NYSE">WTS</a>) shares reached a new 52-week high of $166.11 on Wednesday morning, moving up 0.54%.</li>
<li>AMN Healthcare Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMN#NYSE">AMN</a>) shares broke to a new 52-week high of $110.37 on Wednesday. Shares of the company traded up 2.43%.</li>
<li>Alkermes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALKS#NASDAQ">ALKS</a>) stock on Wednesday broke to a yearly high of $29.54. Shares traded up 1.27%.</li>
<li>Papa John&#39;s International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PZZA#NASDAQ">PZZA</a>) shares hit a yearly high of $129.90. The stock traded up 1.24% on the session.</li>
<li>Premier (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PINC#NASDAQ">PINC</a>) shares broke to $38.23 on Wednesday, setting a new 52-week high with a change of up 2.92%.</li>
<li>TaskUs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TASK#NASDAQ">TASK</a>) shares were up 4.92% for the day, having made a 52-week high of $47.85.</li>
<li>ExlService Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXLS#NASDAQ">EXLS</a>) shares achieved a new 52-week high on Wednesday morning, hitting $124.97 with a daily change of up 1.44%.</li>
<li>Navient (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAVI#NASDAQ">NAVI</a>) shares achieved a new 52-week high on Wednesday morning, hitting $22.23 with a daily change of 0.0% (flat).</li>
<li>Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) stock hit a yearly high price of $98.00. The stock was up 1.57% for the day.</li>
<li>BRP Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRP#NASDAQ">BRP</a>) stock on Wednesday broke to a yearly high of $35.95. Shares traded up 1.62%.</li>
<li>Perficient (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRFT#NASDAQ">PRFT</a>) shares broke to $107.78 on Wednesday, setting a new 52-week high with a change of up 2.38%.</li>
<li>Heska (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSKA#NASDAQ">HSKA</a>) shares were up 0.04% on Wednesday morning to hit a new 52-week high of $270.72.</li>
<li>Docebo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCBO#NASDAQ">DCBO</a>) shares hit a yearly high of $77.17. The stock traded up 4.74% on the session.</li>
<li>Victory Capital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCTR#NASDAQ">VCTR</a>) stock hit a yearly high price of $35.34. The stock was up 0.14% for the day.</li>
<li>Blackrock Municipal 2030 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTT#NYSE">BTT</a>) shares were up 0.17% on Wednesday to hit a new 52-week high of $26.50 for a change of up 0.17%.</li>
<li>Eaton Vance Tax-Managed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETV#NYSE">ETV</a>) shares set a new 52-week high of $16.77 on Wednesday, moving up 0.43%.</li>
<li>Innoviva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVA#NASDAQ">INVA</a>) shares achieved a new 52-week high on Wednesday morning, hitting $16.72 with a daily change of down 0.06%.</li>
<li>Tekla Healthcare Opps (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THQ#NYSE">THQ</a>) shares broke to $25.88 on Wednesday, setting a new 52-week high with a change of up 0.76%.</li>
<li>Amerant Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMTB#NASDAQ">AMTB</a>) shares were up 1.19% on Wednesday to hit a new 52-week high of $24.64 for a change of up 1.19%.</li>
<li>Barings BDC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBDC#NYSE">BBDC</a>) stock made a new 52-week high of $11.09 Wednesday. The stock was down 0.27% for the day.</li>
<li>Cadiz (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDZI#NASDAQ">CDZI</a>) shares broke to a new 52-week high of $14.69 on Wednesday. Shares of the company traded down 0.82%.</li>
<li>The Hackett Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCKT#NASDAQ">HCKT</a>) stock made a new 52-week high of $19.70 Wednesday. The stock was up 3.18% for the day.</li>
<li>Gladstone Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLAD#NASDAQ">GLAD</a>) shares were up 0.76% on Wednesday morning to hit a new 52-week high of $11.99.</li>
<li>CPI Card (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMTS#NASDAQ">PMTS</a>) stock hit a yearly high price of $25.29. The stock was up 3.95% for the day.</li>
<li>Eaton Vance Short (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVG#NYSE">EVG</a>) shares were up 0.36% on Wednesday morning to hit a new 52-week high of $13.87.</li>
<li>Gabelli Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRX#NYSE">GRX</a>) shares hit $13.69 on Wednesday morning, setting a new 52-week high for a change of up 0.12%.</li>
<li>Morgan Stanley Emerg Mkts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSD#NYSE">MSD</a>) shares hit a new 52-week high of $9.62. The stock traded up 0.21% on the session.</li>
<li>Voya Global Advantage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IGA#NYSE">IGA</a>) stock made a new 52-week high of $10.08 Wednesday. The stock was up 0.5% for the day.</li>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) shares were up 57.85% on Wednesday morning to hit a new 52-week high of $35.98.</li>
<li>PhenixFIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFX#NASDAQ">PFX</a>) shares were up 2.76% for the day, having made a 52-week high of $44.00.</li>
</ul>
&nbsp;
Benzinga will continue to provide updates on these equities. Stay tuned for additional news.

Intraday Update

Movers

NAVI

ODFL

PINC

PMTS

PRFT

PZZA

REGN

RGEN

TASK

VCTR

VRPX

Stocks That Hit 52-Week Highs On Wednesday

PhenixFIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFX#NASDAQ">PFX</a>) reported quarterly earnings of $2.02 per share. This is a 876.92 percent increase over losses of $(0.26) per share from the same period last year.

PhenixFIN Q3 EPS $2.02 Up From $(0.26) YoY

Oppenheimer initiates coverage on PhenixFIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFX#NASDAQ">PFX</a>) with a Perform rating.

Initiation

Analyst Ratings

Oppenheimer Initiates Coverage On PhenixFIN with Perform Rating

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
PhenixFIN (NASDAQ:<a href="https://investorplace.com/stock-quotes/pfx-stock-quote/">PFX</a>) just reported results for the fourth quarter of 2023.<ul><li>PhenixFIN reported earnings per share of 89 cents.</li><li>The company reported revenue of $5.68 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT771243">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2023/12/pfx-stock-earnings-phenixfin-for-q4-of-2023/">PFX Stock Earnings: PhenixFIN Reported Results for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

PFX Stock Earnings: PhenixFIN Reported Results for Q4 2023

Preferreds Weekly Review: Drop In Rates Drives New Issuance

PhenixFIN GAAP EPS of $2.19, Total investment income of $5.72M beats by $0.21M

PhenixFIN reports Q2 results

PhenixFIN declares $1.31 dividend

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
PhenixFIN (NASDAQ:<a href="https://investorplace.com/stock-quotes/pfx-stock-quote/">PFX</a>) just reported results for the second quarter of 2024.<ul><li>PhenixFIN reported earnings per share of 28 cents. This was below the analyst estimate for EPS of 79 cents.</li><li>The company reported revenue of $4.66 million.</li><li>This was 16.82% worse than the analyst estimate for revenue of $5.60 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/pfx-stock-earnings-phenixfin-for-q2-of-2024/">PFX Stock Earnings: PhenixFIN Misses EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

PFX Stock Earnings: PhenixFIN Misses EPS, Misses Revenue for Q2 2024

PhenixFIN GAAP EPS of $1.29 beats by $0.64, revenue of $6.23M beats by $1.06M

BDC Weekly Review: Private Lenders Want To Democratize Access

PhenixFIN GAAP EPS of $9.13

ARCC

BBDC

BXSL

OXLC

OXLCL

OXLCM

OXLCN

OXLCO

OXLCP

OXLCZ

PFXNZ

WHFCL

Press Releases

PhenixFIN Corporation Announces Fiscal Year and Fourth Quarter 2023 Financial Results

PhenixFIN Corporation Announces Fiscal First Quarter 2024 Financial Results

PhenixFIN Corporation Announces Fiscal Second Quarter 2024 Financial Results

PhenixFIN Corporation Announces Fiscal Third Quarter 2024 Financial Results

Brightwood and PhenixFIN Provide Senior Secured Credit Facility and Preferred Equity Facility to Support the Refinancing of MB Precision Investment Holdings LLC

PhenixFIN Corporation Announces Fiscal Year and Fourth Quarter 2024 Financial Results

ArrowMark Financial Corp. - Closed End Fund

ArrowMark Financial

Binah Capital Group

Ellington Credit Company Common Shares of Beneficial Interest

Ellington Credit

Great Elm Capital Corp. - Closed End Fund

Great Elm Capital

Great Elm Group

U.S. Global Investors, Inc. - Class A Common Stock

US Global Investors

Heritage Glb

Hennessy Advisors

Highest Performances Holdings Inc. - American Depository Shares

Highest Performances

Investcorp Credit Management BDC, Inc. - Common Stock

Investcorp Credit

Logan Ridge Finance Corporation - Common Stock

Logan Ridge Finance

The Marygold Companies, Inc. Common Stock

Marygold Companies

Monroe Capital Corporation - Closed End Fund

Monroe Cap

OFS Credit Company, Inc. - Closed End Fund

OFS Credit Co

OFS Capital Corporation - Closed End Fund

OFS Capital

Oxford Square Capital Corp. - Closed End Fund

Oxford Square Cap

Portman Ridge Finance Corporation - Closed End Fund

Portman Ridge Finance

Prestige Wealth Inc. - Class A Ordinary Shares

Prestige Wealth

Rand Capital Corporation - Closed End Fund

Rand Capital

Silvercrest Asset Management Group Inc. - Common Stock

Silvercrest Asset Mgmt Gr

SuRo Capital

Santech Holdings Limited - American Depositary Shares

Santech Holdings

180 Degree Capital Corp. - Closed End Fund

180 Degree Capital

WhiteHorse Finance, Inc. - Closed End Fund

Comments

PhenixFIN

PhenixFIN (PFX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga